V-Square Quantitative Management’s DexCom DXCM Stock Holding History

V-Square Quantitative Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$267K	Sell	3,962 -5,656	-59%	-$377K	0.03%	491
2026 Q1	$604K	Buy	9,618 +172	+2%	+$12K	0.06%	274
2025 Q4	$627K	Sell	9,446 -572	-6%	-$37K	0.07%	252
2025 Q3	$674K	Buy	10,018 +679	+7%	+$53.7K	0.11%	137
2025 Q2	$815K	Buy	9,339 +485	+5%	+$38K	0.11%	189
2025 Q1	$605K	Buy	8,854 +490	+6%	+$40K	0.09%	256
2024 Q4	$650K	Sell	8,364 -850	-9%	-$62.9K	0.09%	236
2024 Q3	$618K	Buy	9,214 +1,515	+20%	+$124K	0.09%	247
2024 Q2	$873K	Sell	7,699 -59	-0.8%	-$7.46K	0.14%	135
2024 Q1	$1.08M	Buy	7,758 +1,689	+28%	+$212K	0.15%	111
2023 Q4	$753K	Buy	6,069 +1,700	+39%	+$174K	0.13%	127
2023 Q3	$408K	Buy	4,369 +1,994	+84%	+$225K	0.18%	120
2023 Q2	$305K	Sell	2,375 -802	-25%	-$97K	0.22%	92
2023 Q1	$369K	Buy	+3,177	New	+$356K	0.34%	71

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

V-Square Quantitative Management's DXCM Position: Q2 2026 in Review

V-Square Quantitative Management reduced its DexCom (DXCM) stake by 59% in Q2 2026, selling an estimated $377K and leaving 3,962 shares worth $267K. The position accounts for 0.03% of the portfolio, ranked #491.

V-Square Quantitative Management first reported a position in DXCM in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.08M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

V-Square Quantitative Management held 3,962 shares of DexCom worth $267K as of Q2 2026.
V-Square Quantitative Management sold 5,656 DexCom shares in Q2 2026, an estimated $377K.
DexCom made up 0.03% of V-Square Quantitative Management's portfolio in Q2 2026, its #491 holding.
V-Square Quantitative Management first reported a position in DexCom in Q1 2023 and has held it in 14 quarters since.
V-Square Quantitative Management's DexCom position peaked at $1.08M in Q1 2024.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.